Public

We were asked to provide original documentation submitted as part of King's Health Partners Cancer Biobank's application for an HTA licence.

The HTA was asked to provide documentation - including letters, emails, reports, and meeting minutes - related to concerns about the Wellcome Sanger Institute's compliance with the Human Tissue Act in 2019.

The HTA was asked to provide information on our courier services between 2017 - 2018.

The HTA was asked to provide copies of correspondence sent by Professor Birchall to the HTA in 2007 and 2008.

The HTA was asked to provide information on the total number of organs received by HTA-licensed establishments, distinguishing between living and deceased donations; and also sharing the amount of human tissue received (in weight) by these establishments.

The HTA was asked to provide information on our social media policy and also to give a break down of our expenditure for our organisational accounts per calendar year (Facebook, Twitter).

The HTA was asked to provide information on the quality indicators for ovarian tissue preservation and transplantation for the purpose of fertility preservation, for patients who are undergoing cancer treatment. HTA was also questioned on the ongoing quality checks of post-cryopreservation tissues.

The HTA was asked to provide information on reportable incidents that took place in the 2017 calendar year.

The HTA was asked to provide details on the number of church officials currently working as representatives of the HTA.

The HTA was asked to provide information on its intranet software.